In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Wellness Market News: Dr. Seltzer, Reon, Designer Keto Launches; VSI, Halo Hires; HempMeds, Kannaway Milestone

Executive Summary

Culturelle probiotic partners with Persona Nutrition; HempMeds, Kannaway CBD supplements listed in Prescribers' Digital Reference; Dr. Seltzer’s Hangover HelpeRx relaunches with hemp extract formula; Designer Protein rolls out keto adaptogenic protein powder; Reon Revive delivers energy on tongue; Touchstone offers Calm Advanced hemp oil; Halo has celebrity trainer as advisor; amd Vitamin Shoppe names sales VP.

You may also be interested in...



Medical Marijuana Inc. Claims First CBD Supplement Approval In EU

Bulgaria has granted US-based Medical Marijuana Inc. the right to sell CBD as a supplement in a first for an EU country. The move, which will see CBD regulated as a traditional food, puts Bulgaria directly at odds with the European Commission, which recently classified the cannabis plant extract as a novel food.

Health And Wellness Industry News: VSI, Hain, Neogen Executive Moves, CBD Deal

Vitamin Shoppe appoints CTO; Hain Celestial names two executives to North America management, eliminating region's CEO post; Neogen international VP; Caliva, Tarukino CBD tech deal.

Vitamin Shoppe Adds Marketing Chief, Flips Switch On Vendor Incubator

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS148538

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel